KPV
KPV is a tripeptide derived from the C-terminal of alpha-melanocyte-stimulating hormone (alpha-MSH 11-13), studied in anti-inflammatory and gut-barrier research models.
We have not published an audit on KPV. Everything below is reference material, not our own reading of the literature, treat it as a starting point for questions, not as a grade.
How it is thought to work
Potential anti-inflammatory signaling via melanocortin pathways.
KPV is a tiny three-amino-acid fragment of a natural hormone that reduces inflammation, especially in the gut, by calming specific inflammatory signals (like NF-kB) without broadly suppressing the immune system, and it can be taken orally because a gut transporter called PepT1 absorbs it, with more of that transporter present in inflamed tissue.
Reported side effects
KPV is generally reported as well-tolerated, with the most commonly noted effects being mild injection-site irritation, occasional mild headache, and occasional GI upset at higher oral doses, though no formal human safety trial has been completed.
Who should avoid it
People who are pregnant or breastfeeding, have a known peptide hypersensitivity, have active complex infections, or are on prescription immunomodulators for autoimmune or inflammatory bowel disease should avoid KPV or consult a clinician before considering it.